Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cognitive Processes and Functions in Patients With Type 2 Diabetes in Comparison to Pre-Diabetic Patients Pubmed



Nazaribadie M1 ; Asgari K2 ; Amini M3 ; Ahmadpanah M4 ; Nazaribadie M1 ; Jamlipaghale S6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Psychology Ward, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. Department of Psychology, School of Psychology and Educational Sciences, University of Isfahan, Isfahan, Iran
  3. 3. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Research Center for Behavioral Disorders and Substances Abuse, Hamadan University of Medical Sciences, Hamadan, Iran
  5. 5. Department of Nursing, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran
  6. 6. Department of Psychology, School of Human Sciences, Alzahra University, Tehran, Iran

Source: Journal of Research in Health Sciences Published:2013


Abstract

Background: Type 2 diabetes is an important risk factor for cognitive decline in diabetic patients. The main goal of this study was the assessment of memory, attention and visuospatial ability dysfunctions in patients with type 2 diabetes in comparison to prediabetic patients and normal subjects in Endocrine and Metabolism Center of Isfahan City from April 2011 to July 2011. Methods: The sample comprised of 32 patients with type 2 diabetes, 28 pre-diabetic patients and 30 healthy individuals. Memory, attention and visuospatial ability were assessed by Rey Complex Figure Test (RCFT), Paced Auditory Serial Addition Test (PASAT) and sub tests of Wechsler Adult Intelligence Scale-Revised (WAIS-R). Results: The pair wise comparisons of cognitive functions among three groups, suggesting a significant difference between diabetic and normal groups in PASAT3. PASAT2, RCFT (recall trial) and Symbol coding (P=0.003, P=0.009, P=0.010, and P<0.001, respectively). But there was no difference in copy trial of RCFT and block design between two groups (P=0.170, P=0.490). There was significant difference between pre-diabetic group and normal group in recall trial of RCFT (P=0.020), as well as significant difference between diabetes type 2 and pre-diabetic group in symbol coding (P=0.001). Conclusion: There were significant differences in cognitive functions in patient with type2 diabetes, pre-diabetic patients and normal individuals. Thus monitoring neuropsychological status besides controlling levels of blood sugar in these patients is important.
Related Docs
View other Related Docs
1. Executive Functions and Information Processing in Patients With Type 2 Diabetes in Comparison to Pre-Diabetic Patients, Journal of Diabetes and Metabolic Disorders (2014)
2. A Study of Cognitive Functioning in Type 2 Diabetics in Comparison With the Control Group, Advances in Environmental Biology (2014)
3. Association Between Cognitive Impairment and Blood Pressure Among Patients With Type Ii Diabetes Mellitus in Southern Iran, Diabetes, Metabolic Syndrome and Obesity (2020)
4. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)
5. The Visceral Adiposity Index in Comparison With Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes, Canadian Journal of Diabetes (2016)
6. Comparison of Systolic and Diastolic Blood Pressure With Pulse Pressure and Mean Arterial Pressure for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Endokrynologia Polska (2011)
7. Speech Recognition in Noise in Patients With Type Ii Diabetes, Indian Journal of Otology (2020)
8. The Effectiveness of Cognitive-Behavioral Stress Mmanagement Training on Glycemic Control and Depression in Patients With Type 2 Diabetes, Iranian Journal of Endocrinology and Metabolism (2009)
Experts (# of related papers)
View all Related Experts
Majid Barekatain (3)
Mohammad Reza Maracy (3)
Other Related Docs
9. Progression to Impaired Glucose Metabolism in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran, Diabetes/Metabolism Research and Reviews (2009)
10. Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-Induced Memory Impairment in Mice, Clinical Psychopharmacology and Neuroscience (2020)
11. Incidence of Metabolic Syndrome and Its Risk Factors Among Type 2 Diabetes Clinic Attenders in Isfahan, Iran, Endokrynologia Polska (2012)
12. Diabetes Mellitus and Risk of Incident Dementia in Apoe E4 Carriers: An Updated Meta-Analysis, BMC Neuroscience (2024)
13. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
14. Comparison of Body Mass Index With Abdominal Obesity Indicators and Waist-To-Stature Ratio for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Obesity Research and Clinical Practice (2010)
15. The Effect of Intelligence Self-Control Program on the Quality of Life of the Adolescents With Type I Diabetes, Iranian Journal of Nursing and Midwifery Research (2020)
16. The Effect of Astaxanthin Supplementation on Cognitive Function and Depression in Patients With Type 2 Diabetes: A Double-Blind, Randomised Controlled Trial, Journal of Health System Research (2020)
17. A Comprehensive Investigation of the Associations Between Tensor-Based Morphometry Indices and Executive Functions, Memory, Language, and Visuospatial Abilities in Patients in the Alzheimer's Disease Continuum, Clinical Neurology and Neurosurgery (2024)
18. Incidence of Type 2 Diabetes by Hba1c and Ogtt: The Isfahan Diabetes Prevention Study, Acta Diabetologica (2012)
19. Impact of Health Literacy, Self-Efficacy, and Outcome Expectations on Adherence to Self-Care Behaviors in Iranians With Type 2 Diabetes, Oman Medical Journal (2016)
20. Dexamethasone Stress Test: A Pilot Clinical Study for Identification of Individuals Highly Prone to Develop Type 2 Diabetes, Endocrine Practice (2018)
21. Evaluation of Hearing Loss in Juvenile Insulin Dependent Patients With Diabetes Mellitus, Journal of Research in Medical Sciences (2011)
22. The Relationship of Laboratory Results and Cognitive Function in Patient With Type I and Type Ii Diabetes Mellitus, Journal of Isfahan Medical School (2013)
23. Comparison of Glycated Hemoglobin With Fasting Plasma Glucose in Definition of Glycemic Component of the Metabolic Syndrome in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2012)
24. Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran: Prevalence and Risk Factors, Metabolic Syndrome and Related Disorders (2007)
25. Comparison of Metabolic Syndrome With Glucose Measurement for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2009)
26. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients With Type Ii Diabetes, Journal of Kerman University of Medical Sciences (2013)
27. Diabetes and Impaired Glucose Regulation in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran: Prevalence and Risk Factors, Review of Diabetic Studies (2007)
28. The Effect of Nutrition Education on Risk Factors of Cardiovascular Diseases in Elderly Patients With Type 2 Diabetes: A Randomized Controlled Trial, Iranian Journal of Endocrinology and Metabolism (2011)
29. One-Year Follow-Up Evaluation of Cognitive Function in Patients With Coronary Artery Disease and Over 65 Years of Age in Isfahan City, Iran, Journal of Isfahan Medical School (2017)
30. Association Between Cognitive Function and Parameters of Echocardiography and Coronary Artery Angiography; [Associacao Entre a Funcao Cognitiva E Parametros De Ecocardiografia E Angiografia Da Arteria Coronaria], Arquivos de Neuro-Psiquiatria (2018)
31. Weight Status of the First-Degree Relatives of Patients With Type 2 Diabetes Based on the Glucose Tolerance Test, Journal of Research in Medical Sciences (2012)
32. Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Annals of Nutrition and Metabolism (2016)
33. Comparison of Fasting Glucose With Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2009)
34. Finnish Diabetes Risk Score to Predict Type 2 Diabetes in the Isfahan Diabetes Prevention Study, Diabetes Research and Clinical Practice (2013)
35. Investigating Patterns of Memory Impairment in Ischemic Stroke in an Iranian Population, Applied Neuropsychology:Adult (2018)
36. Evaluation of the Finnish Diabetes Risk Score (Findrisc) As a Screening Tool for the Metabolic Syndrome, The review of diabetic studies : RDS (2013)
37. Area Under the Curve During Ogtt in First-Degree Relatives of Diabetic Patients As an Efficient Indicator of Future Risk of Type 2 Diabetes and Prediabetes, Clinical Endocrinology (2017)
38. Normal Fasting Plasma Glucose and Risk of Prediabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2011)
39. Psychosomatic Complaints Profile in Patients With Type 2 Diabetes: A Matched Case-Control Study, Egyptian Journal of Neurology, Psychiatry and Neurosurgery (2019)
40. The Functional, Communicative, and Critical Health Literacy (Fcchl) Scales: Cross-Cultural Adaptation and the Psychometric Properties of the Iranian Version, Iranian Red Crescent Medical Journal (2017)
41. Association Between Cognitive Capacity and Metabolic Indices in Patients With Neuropsychiatric Disorders, Journal of Education and Health Promotion (2023)